Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Corporate Governance & Structure

Newron is committed to good corporate governance. Our Board of Directors regularly review our procedures to ensure that we are transparent and accountable to our shareholders.